Mechanism of albuminuria associated with cardiovascular disease and kidney disease

被引:32
|
作者
Russo, LM
Comper, WD
Osicka, TM
机构
[1] AusAm Biotechnol Inc, New York, NY 10022 USA
[2] Massachusetts Gen Hosp, Dept Med, Renal Unit, Program Membrane Biol, Charlestown, MA USA
[3] Harvard Univ, Sch Med, Charlestown, MA USA
[4] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia
关键词
lysosome; albumin degradation; albumm-derived fragments;
D O I
10.1111/j.1523-1755.2004.09218.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The major underlying factors associated with tissue damage and fibrosis in cardiovascular and kidney disease are the up-regulation and action of growth factors such as transforming growth factor-beta (TGF-Pbeta) and cytokines produced in response to changes in systemic factors, particularly blood pressure or hyperalycemia. This study identifies the relationship of elevated levels of TGF-beta to increased levels of intact albumin in the urine (micro- and macroalbuminuria). This mechanism may be directly linked to the effect of TGF-beta on albumin uptake and the lysosomal breakdown of filtered albumin by proximal tubular cells prior to excretion.
引用
收藏
页码:S67 / S68
页数:2
相关论文
共 50 条
  • [31] Albuminuria: a target for clinical trials in kidney disease?
    Glassock, Richard J.
    NATURE REVIEWS NEPHROLOGY, 2019, 15 (05) : 257 - 258
  • [32] Albuminuria: a target for clinical trials in kidney disease?
    Richard J. Glassock
    Nature Reviews Nephrology, 2019, 15 : 257 - 258
  • [33] Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
    Lees, Jennifer S.
    Welsh, Claire E.
    Celis-Morales, Carlos A.
    Mackay, Daniel
    Lewsey, James
    Gray, Stuart R.
    Lyall, Donald M.
    Cleland, John G.
    Gill, Jason M. R.
    Jhund, Pardeep S.
    Pell, Jill
    Sattar, Naveed
    Welsh, Paul
    Mark, Patrick B.
    NATURE MEDICINE, 2019, 25 (11) : 1753 - +
  • [34] Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
    Jennifer S. Lees
    Claire E. Welsh
    Carlos A. Celis-Morales
    Daniel Mackay
    James Lewsey
    Stuart R. Gray
    Donald M. Lyall
    John G. Cleland
    Jason M. R. Gill
    Pardeep S. Jhund
    Jill Pell
    Naveed Sattar
    Paul Welsh
    Patrick B. Mark
    Nature Medicine, 2019, 25 : 1753 - 1760
  • [35] Cardiovascular Disease and Diabetic Kidney Disease
    Maqbool, Muhammad
    Cooper, Marke.
    Jandeleit-Dahm, Karin A. M.
    SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 217 - 232
  • [36] Chronic kidney disease and cardiovascular disease
    Bondugulapati, Laxmi Narsimha Rao
    Shandilya, Saurabh
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (04) : 353 - 354
  • [37] Cardiovascular Disease in Chronic Kidney Disease
    Shoji, Tetsuo
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S140 - S140
  • [38] Introduction: Kidney Disease and Cardiovascular Disease
    Nangaku, Masaomi
    SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 207 - 207
  • [39] Cardiovascular disease and subsequent kidney disease
    Elsayed, Essam F.
    Tighiouart, Hocine
    Griffith, John
    Kurth, Tobias
    Levey, Andrew S.
    Salem, Deeb
    Sarnak, Mark J.
    Weiner, Daniel E.
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (11) : 1130 - 1136
  • [40] Cardiovascular disease and chronic kidney disease
    Gargiulo, Richard
    Suhail, Faten
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (09): : 403 - 413